The hypotonic, weak baby: an approach to neonatal neuromuscular disease

Dr Brandsema discusses a suggested approach to timely and accurate diagnosis of neuromuscular disease in neonates

Dr. Brandsema has disclosed that he was/is on the speakers bureau for Biogen; was/is a consultant/advisor and grant/research support recipient for AveXis, Inc., Biogen, PTC Therapeutics, Sarepta Therapeutics, Alexion Pharmaceuticals, Inc., Cytokinetics.